CN102863435A - 2-[[4-fluoro-3-(trifluoromethyl) phenyl] amino]-4-pyridyl-5-thiazole formaldehyde and preparation method of reduction product thereof - Google Patents

2-[[4-fluoro-3-(trifluoromethyl) phenyl] amino]-4-pyridyl-5-thiazole formaldehyde and preparation method of reduction product thereof Download PDF

Info

Publication number
CN102863435A
CN102863435A CN2012103588270A CN201210358827A CN102863435A CN 102863435 A CN102863435 A CN 102863435A CN 2012103588270 A CN2012103588270 A CN 2012103588270A CN 201210358827 A CN201210358827 A CN 201210358827A CN 102863435 A CN102863435 A CN 102863435A
Authority
CN
China
Prior art keywords
pyridyl
phenyl
trifluoromethyl
fluoro
amino
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CN2012103588270A
Other languages
Chinese (zh)
Other versions
CN102863435B (en
Inventor
王伟
方海林
范大和
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Changshu Zijin Intellectual Property Service Co ltd
Original Assignee
Yangcheng Institute of Technology
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Yangcheng Institute of Technology filed Critical Yangcheng Institute of Technology
Priority to CN201210358827.0A priority Critical patent/CN102863435B/en
Publication of CN102863435A publication Critical patent/CN102863435A/en
Application granted granted Critical
Publication of CN102863435B publication Critical patent/CN102863435B/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Abstract

The invention discloses a 2-[[4-fluoro-3-(trifluoromethyl) phenyl] amino]-4-pyridyl-5-thiazole formaldehyde and a preparation method of a reduction product thereof. The preparation method is characterized by including the steps: using 2-[[4-fluoro-3-(trifluoromethyl) phenyl] amino]-4-pyridyl thiazole and paraformaldehyde as raw materials to prepare the 2-[[4-fluoro-3-(trifluoromethyl) phenyl] amino]-4-pyridyl-5-thiazole formaldehyde by means of one-step hydroformylation reaction; and enabling the prepared 2-[[4-fluoro-3-(trifluoromethyl) phenyl] amino]-4-pyridyl-5-thiazole formaldehyde to react with NaBH4, so that the reduction product of the 2-[[4-fluoro-3-(trifluoromethyl) phenyl] amino]-4-pyridyl-5-thiazole formaldehyde, namely, 2-[[4-fluoro-3-(trifluoromethyl) phenyl] amino]-4-pyridyl-5-thiazole methanol is prepared. The preparation method adopting the one-step hydroformylation reaction is simple in reaction process, high in yield and good in environmental friendliness.

Description

A kind of 2-[[4-fluoro-3-(trifluoromethyl) phenyl] amino]-preparation method of 4-pyridyl-5-thiazole carboxaldehyde and reduzate thereof
Technical field:
The present invention relates to a kind of 2-[[4-fluoro-3-(trifluoromethyl) phenyl] amino]-preparation method of 4-pyridyl-5-thiazole carboxaldehyde and reduzate thereof, belong to chemosynthesis technical field.
Background technology:
α 7NAChR (nAChRs) is five yuan of part gated ion channels of a class, extensively is distributed in the neural system (to comprise pallium and hippocampus).The nAChRs of activation causes the inward electric current of a rapid deactivation, and it mainly is to enter the activating cells kinases by calcium channel, and further pharmacological research shows, activates α 7Passage improves cognitive performance, comprises the disappearance of attention, study, working memory, cognitive handiness.2-[[4-fluoro-3-(trifluoromethyl) phenyl] amino]-4-pyridyl-5-thiazole derivative is a kind of α of novel highly selective 7NAChR.Patent WO03015773A2, WO2007031440A2 have reported that this compounds is as a kind of novel α 7The effect of nAChR in relative disease.
Synthetic 2-[[4-fluoro-3-(trifluoromethyl) phenyl of document WO 2007031440A2 report] amino]-method of 4-pyridyl-5-thiazole methyl alcohol is to obtain 2-[[4-fluoro-3-(trifluoromethyl) phenyl with 1-(6-amino-3-pyridyl) ethyl ketone and the reaction of 1-(4-fluoro-3-(trifluoromethyl) phenyl) thiocarbamide] amino]-the 4-pyridyl thiazole, then pass through bromination, lower to reacting with butyllithium at-78 ℃ again, obtain aldehyde radical product 2-[[4-fluoro-3-(trifluoromethyl) phenyl after adding again DMF] amino]-4-pyridyl-5-thiazole carboxaldehyde, and then reduction obtains target product under lithium aluminium hydride, wherein need in advance bromo activation before the aldehyde radical reaction, and reaction needed is carried out at low temperatures, the overall yield of two-step reaction about 55%, in the reaction bromo again debrominate produce a large amount of pollutions.Reported a kind of other route of synthesis among the patent WO2009114552A1, can directly obtain the 2-[(3-aminomethyl phenyl with formaldehyde reaction) amino]-4-pyridyl-5-thiazole carboxaldehyde, then reaction can not be changed fully, follow-uply can obtain the 2-[(3-aminomethyl phenyl by the Manganse Dioxide oxidation) amino]-4-pyridyl-5-thiazole carboxaldehyde, wherein need to use the oxygenant of 7 times of molar weights.The overall yield of two-step reaction is about 30%.
Based on the above-mentioned situation of prior art, the applicant makes the present invention.
Summary of the invention:
A first aspect of the present invention purpose provides 2-[[4-fluoro-3-(trifluoromethyl) phenyl that a kind of reaction process is simple and reaction yield is high, the feature of environmental protection is good] amino]-preparation method of 4-pyridyl-5-thiazole carboxaldehyde.
The technical scheme that the present invention takes for achieving the above object is as follows:
A kind of 2-[[4-fluoro-3-(trifluoromethyl) phenyl] amino]-preparation method of 4-pyridyl-5-thiazole carboxaldehyde, it is characterized in that, may further comprise the steps: take 2-[[4-fluoro-3-(trifluoromethyl) phenyl] amino]-4-pyridyl thiazole and Paraformaldehyde 96 are as raw material, and step aldehyde radical reaction prepares 2-[[4-fluoro-3-(trifluoromethyl) phenyl] amino]-4-pyridyl-5-thiazole carboxaldehyde.
Further arrange and be:
In the reaction:
2-[[4-fluoro-3-(trifluoromethyl) phenyl] amino]-mol ratio of 4-pyridyl thiazole and Paraformaldehyde 96 is 1:5 ~ 15.
2-[[4-fluoro-3-(trifluoromethyl) phenyl] amino]-mol ratio of 4-pyridyl thiazole and Paraformaldehyde 96 is 1:5 ~ 10.
Described reaction is carried out in the presence of solvent, and solvent is selected from acetonitrile or ethanolic soln.
Described reaction is carried out in the presence of alkali, and the alkali that uses is triethylamine, diethylamine or Pyrrolidine.Be preferably triethylamine, 2-[[4-fluoro-3-(trifluoromethyl) phenyl] amino]-molar ratio of 4-pyridyl thiazole and alkali is 1:2 ~ 5.
Described reaction is carried out in the presence of lewis acidic, and Lewis acid is magnesium chloride, zinc chloride, iron(ic) chloride or aluminum chloride.
Described Lewis acid is magnesium chloride, 2-[[4-fluoro-3-(trifluoromethyl) phenyl] amino]-molar ratio of 4-pyridyl thiazole and magnesium chloride is 1:1.
A second aspect of the present invention purpose provides a kind of 2-[[4-fluoro-3-(trifluoromethyl) phenyl] amino]-4-pyridyl-5-thiazole carboxaldehyde prepares the method for its reduzate, it is characterized in that: with 2-[[4-fluoro-3-(trifluoromethyl) phenyl of preparation] and amino]-4-pyridyl-5-thiazole carboxaldehyde and NaBH 4Reaction, preparation 2-[[4-fluoro-3-(trifluoromethyl) phenyl] amino]-reduzate of 4-pyridyl-5-thiazole carboxaldehyde is 2-[[4-fluoro-3-(trifluoromethyl) phenyl] amino]-4-pyridyl-5-thiazole methyl alcohol.
Further: 2-[[4-fluoro-3-(trifluoromethyl) phenyl] amino]-4-pyridyl-5-thiazole carboxaldehyde and NaBH 4Mol ratio be 3:1, reduction reaction is carried out in methanol solution, room temperature reaction 2 hours, with behind the ethyl acetate extraction, anhydrous magnesium sulfate drying product 2-[[4-fluoro-3-(trifluoromethyl) phenyl] amino]-4-pyridyl-5-thiazole methyl alcohol.
Principle of the present invention and the chemical reaction process that relates to are as follows:
Reaction mechanism: the present invention is take 2-[[4-fluoro-3-(trifluoromethyl) phenyl] amino]-the 4-pyridyl thiazole is as raw material, by directly carrying out the reaction of single stage method aldehyde radical with Paraformaldehyde 96, prepare 2-[[4-fluoro-3-(trifluoromethyl) phenyl] amino]-4-pyridyl-5-thiazole carboxaldehyde, and then obtain 2-[[4-fluoro-3-(trifluoromethyl) phenyl by reduction] amino]-4-pyridyl-5-thiazole methyl alcohol.Wherein: the productive rate of single stage method aldehyde radical reaction than the obviously raising of productive rate (55%) of existing two-step approach reaction, and can reduce the environmental pollution that bromo-reaction brings in the two-step reaction 76%.
The chemical equation that the present invention relates to:
Figure 2012103588270100002DEST_PATH_IMAGE001
In the above-mentioned reaction formula:
Formula 1 is 1-(4-fluoro-3-(trifluoromethyl) phenyl) thiocarbamide, hereinafter referred to as compound 1.
Formula 2 is 2-bromo-1-(4-pyridyl) ethyl ketone hydrobromate, hereinafter referred to as compound 2.
Formula 3 is 2-[[4-fluoro-3-(trifluoromethyl) phenyl] amino]-the 4-pyridyl thiazole, hereinafter referred to as compound 3.
Formula 4 is 2-[[4-fluoro-3-(trifluoromethyl) phenyl] amino]-4-pyridyl-5-thiazole carboxaldehyde, hereinafter referred to as compound 4.
Formula 5 is 2-[[4-fluoro-3-(trifluoromethyl) phenyl] amino]-4-pyridyl-5-thiazole methyl alcohol, hereinafter referred to as compound 5.
The invention will be further described below in conjunction with the drawings and specific embodiments.
Description of drawings:
Fig. 1 be compound 4 ( 1H NMR, 400M, solvent DMSO) nuclear magnetic resonance map;
Fig. 2 be compound 5 ( 1H NMR, 400M, solvent DMSO) nuclear magnetic resonance map.
Embodiment:
Synthesizing of embodiment 1, compound 3.
With compound 1 (43 g, 0.18 mol) with compound 2 (60.7 g, 0.216 mol) be dissolved in the ethanol of 2L stirring and refluxing 4 hours, then be cooled to room temperature, concentrated, residuum is poured in the saturated sodium carbonate solution, filter, and with 100mL water washing three times, vacuum-drying obtains brown solid 54 g, productive rate 88%.
Synthesizing of embodiment 2, compound 4.
With compound 3(0.1mol, 33.9g) be dissolved in the acetonitrile solution of 100mL, stir the lower Paraformaldehyde 96 (1mol that adds, 30g), triethylamine (0.35mol, 35.3g), and magnesium chloride (0.1mol, 9.5g), then refluxed 2 hours, TLC controls reaction end, and the most of acetonitrile of reclaim under reduced pressure is poured into reaction solution in 5% the dilute hydrochloric acid of 300mL, then use extracted with diethyl ether (4 * 100 mL), anhydrous magnesium sulfate drying, the concentrated solid product (28 g, productive rate 76%) that obtains yellow.
Synthesizing of embodiment 3, compound 5.
NaBH 4(2.27 g, 60 mmol) slowly join under the room temperature in the 400mL methanol solution of compound 4 (7.35 g, 20 mmol), the reaction stirring at room is about 2 hours, point sample is determined reaction end, then reaction solution is poured in the 300mL water, is extracting with ethyl acetate (5 * 200 mL), use respectively again the saturated common salt water washing, anhydrous magnesium sulfate drying, the concentrated solid product (6.43 g, productive rate 87%) that obtains yellow.

Claims (10)

1. a 2-[[4-fluoro-3-(trifluoromethyl) phenyl] amino]-preparation method of 4-pyridyl-5-thiazole carboxaldehyde, it is characterized in that, may further comprise the steps: take 2-[[4-fluoro-3-(trifluoromethyl) phenyl] amino]-4-pyridyl thiazole and Paraformaldehyde 96 are as raw material, and step aldehyde radical reaction prepares 2-[[4-fluoro-3-(trifluoromethyl) phenyl] amino]-4-pyridyl-5-thiazole carboxaldehyde.
2. a kind of 2-[[4-fluoro-3-according to claim 1 (trifluoromethyl) phenyl] amino]-preparation method of 4-pyridyl-5-thiazole carboxaldehyde, it is characterized in that: 2-[[4-fluoro-3-(trifluoromethyl) phenyl] amino]-mol ratio of 4-pyridyl thiazole and Paraformaldehyde 96 is 1:5 ~ 15.
3. a kind of 2-[[4-fluoro-3-according to claim 1 (trifluoromethyl) phenyl] amino]-preparation method of 4-pyridyl-5-thiazole carboxaldehyde, it is characterized in that: 2-[[4-fluoro-3-(trifluoromethyl) phenyl] amino]-mol ratio of 4-pyridyl thiazole and Paraformaldehyde 96 is 1:5 ~ 10.
4. a kind of 2-[[4-fluoro-3-according to claim 1 (trifluoromethyl) phenyl] amino]-preparation method of 4-pyridyl-5-thiazole carboxaldehyde, it is characterized in that: described reaction is carried out in the presence of solvent, and solvent is selected from acetonitrile or ethanolic soln.
5. a kind of 2-[[4-fluoro-3-according to claim 1 (trifluoromethyl) phenyl] amino]-preparation method of 4-pyridyl-5-thiazole carboxaldehyde, it is characterized in that: described reaction is carried out in the presence of alkali, and the alkali that uses is triethylamine, diethylamine or Pyrrolidine.
6. a kind of 2-[[4-fluoro-3-according to claim 5 (trifluoromethyl) phenyl] amino]-preparation method of 4-pyridyl-5-thiazole carboxaldehyde, it is characterized in that: described alkali is triethylamine, 2-[[4-fluoro-3-(trifluoromethyl) phenyl] amino]-molar ratio of 4-pyridyl thiazole and alkali is 1:2 ~ 5.
7. a kind of 2-[[4-fluoro-3-according to claim 1 (trifluoromethyl) phenyl] amino]-preparation method of 4-pyridyl-5-thiazole carboxaldehyde, it is characterized in that: described reaction is carried out in the presence of lewis acidic, and Lewis acid is magnesium chloride, zinc chloride, iron(ic) chloride or aluminum chloride.
8. a kind of 2-[[4-fluoro-3-according to claim 7 (trifluoromethyl) phenyl] amino]-preparation method of 4-pyridyl-5-thiazole carboxaldehyde, it is characterized in that: described Lewis acid is magnesium chloride, 2-[[4-fluoro-3-(trifluoromethyl) phenyl] amino]-molar ratio of 4-pyridyl thiazole and magnesium chloride is 1:1.
9. A kind of 2-[[4-fluoro-3-(trifluoromethyl) phenyl of each preparation of claim 1-8] amino]-4-pyridyl-5-thiazole carboxaldehyde prepares the method for its reduzate, it is characterized in that: with 2-[[4-fluoro-3-(trifluoromethyl) phenyl of preparation] and amino]-4-pyridyl-5-thiazole carboxaldehyde and NaBH 4 Reaction, preparation 2-[[4-fluoro-3-(trifluoromethyl) phenyl] amino]-reduzate of 4-pyridyl-5-thiazole carboxaldehyde is 2-[[4-fluoro-3-(trifluoromethyl) phenyl] amino]-4-pyridyl-5-thiazole methyl alcohol.
10. A kind of 2-[[4-fluoro-3-according to claim 9 (trifluoromethyl) phenyl] amino]-preparation method of 4-pyridyl-5-thiazole carboxaldehyde reduzate, it is characterized in that: 2-[[4-fluoro-3-(trifluoromethyl) phenyl] amino]-4-pyridyl-5-thiazole carboxaldehyde and NaBH 4 Mol ratio be 3:1, reduction reaction is carried out in methanol solution, room temperature reaction 2 hours, with behind the ethyl acetate extraction, anhydrous magnesium sulfate drying product 2-[[4-fluoro-3-(trifluoromethyl) phenyl] amino]-4-pyridyl-5-thiazole methyl alcohol.
CN201210358827.0A 2012-09-25 2012-09-25 2-[[4-fluoro-3-(trifluoromethyl) phenyl] amino]-4-pyridyl-5-thiazole formaldehyde and preparation method of reduction product thereof Active CN102863435B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201210358827.0A CN102863435B (en) 2012-09-25 2012-09-25 2-[[4-fluoro-3-(trifluoromethyl) phenyl] amino]-4-pyridyl-5-thiazole formaldehyde and preparation method of reduction product thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201210358827.0A CN102863435B (en) 2012-09-25 2012-09-25 2-[[4-fluoro-3-(trifluoromethyl) phenyl] amino]-4-pyridyl-5-thiazole formaldehyde and preparation method of reduction product thereof

Publications (2)

Publication Number Publication Date
CN102863435A true CN102863435A (en) 2013-01-09
CN102863435B CN102863435B (en) 2015-02-18

Family

ID=47442596

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201210358827.0A Active CN102863435B (en) 2012-09-25 2012-09-25 2-[[4-fluoro-3-(trifluoromethyl) phenyl] amino]-4-pyridyl-5-thiazole formaldehyde and preparation method of reduction product thereof

Country Status (1)

Country Link
CN (1) CN102863435B (en)

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10038436A1 (en) * 2000-08-07 2002-03-28 Siemens Ag New 5-acceptor-functionalized 2-diarylamino thiophene or thiazole derivatives, especially useful for making organic light-emitting diodes
CN1541097A (en) * 2001-08-13 2004-10-27 ղɭҩҵ���޹�˾ 2-amino-4, 5-trisubstituted thiazolyl derivatives
WO2007031440A2 (en) * 2005-09-13 2007-03-22 Janssen Pharmaceutica N.V. 2-aniline-4-aryl substituted thiazole derivatives
WO2009114552A1 (en) * 2008-03-10 2009-09-17 The Board Of Trustees Of The Leland Stanford Junior University Heteroaryl compounds, compositions, and methods of use in cancer treatment

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10038436A1 (en) * 2000-08-07 2002-03-28 Siemens Ag New 5-acceptor-functionalized 2-diarylamino thiophene or thiazole derivatives, especially useful for making organic light-emitting diodes
CN1541097A (en) * 2001-08-13 2004-10-27 ղɭҩҵ���޹�˾ 2-amino-4, 5-trisubstituted thiazolyl derivatives
WO2007031440A2 (en) * 2005-09-13 2007-03-22 Janssen Pharmaceutica N.V. 2-aniline-4-aryl substituted thiazole derivatives
CN101263130A (en) * 2005-09-13 2008-09-10 詹森药业有限公司 2-aniline-4-aryl substituted thiazole derivatives
WO2009114552A1 (en) * 2008-03-10 2009-09-17 The Board Of Trustees Of The Leland Stanford Junior University Heteroaryl compounds, compositions, and methods of use in cancer treatment

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
MICHAEL P. HAY,等: "4-Pyridylanilinothiazoles That Selectively Target von Hippel-Lindau Deficient Renal Cell Carcinoma Cells by Inducing Autophagic Cell Death", 《JOURNAL OF MEDICINAL CHEMISTRY》 *
杨征敏,等: "新型除草剂丙酯草醚的微量合成", 《核农学报》 *

Also Published As

Publication number Publication date
CN102863435B (en) 2015-02-18

Similar Documents

Publication Publication Date Title
CN106977572B (en) A method of using hyodesoxycholic acid as Material synthesis lithocholic acid
CN108863845A (en) A kind of preparation method of trifloxystrobin and its intermediate
CN113402511B (en) Preparation method of topramezone
CN109942593A (en) A kind of total synthesis method of racemization hanfangchin A
CN102977050B (en) Method for synthesizing 2-benzothiazolyl dimethylacetal and 2-benzothiazol formaldehyde
CN103059011B (en) Three metal organic frames based on Co(II) ion as well as synthesis method and application thereof
CN104529935B (en) Method for synthesizing ethyl 2-(3-aldehyde-4-isobutyloxyphenyl)-4-methylthiazole-5-formate
CN102863435B (en) 2-[[4-fluoro-3-(trifluoromethyl) phenyl] amino]-4-pyridyl-5-thiazole formaldehyde and preparation method of reduction product thereof
CN103012268B (en) Novel preparation method for ivabradine
CN109928926B (en) Improved preparation process of chemical luminescent APS-5 key intermediate
CN103665084A (en) Method for preparing abiraterone acetate
CN104923297A (en) Iridium catalyst used for catalyzing ammonia borane hydrolysis hydrogen production process, and preparation method and application thereof
CN110041308A (en) A kind of high symmetry sandwich structure imines Zn complex
CN105272918B (en) Halogenation -1- alkyl -3- vinyl -2,4,5- triarylimidazoles and preparation method and purposes
CN114213424A (en) Synthetic method of furan [3, 2-b ] pyridine derivative
CN107200763A (en) A kind of method using chenodeoxycholic acid as Material synthesis lithocholic acid
CN110283040B (en) Synthetic method of 3-methyl-D3-benzyl bromide
KR20220029525A (en) Method of preparing milrinone derivatives including a continuous flow process
CN102363591A (en) Method for preparing 4,4'-difluorobenzil
CN102558068A (en) Water-phase synthetic benzimidazole compound and crystallization method thereof
CN108727323B (en) Method for catalytically synthesizing trifluoromethyl substituted homoisoflavone compound by using N-heterocyclic carbene
CN101824010B (en) Method for synthesizing 4-aryl-4,5-dihydrofuran
CN109265403A (en) A kind of synthetic method of benzimidazole and its derivative
CN105618145B (en) A kind of preparation method of three [three (a sodium sulfonate phenyl) phosphines] chlorination rhodium catalysts
CN114773324B (en) Preparation method of difenoconazole

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
CB03 Change of inventor or designer information

Inventor after: Fan Dahe

Inventor after: Fang Hailin

Inventor after: Wang Wei

Inventor before: Wang Wei

Inventor before: Fang Hailin

Inventor before: Fan Dahe

COR Change of bibliographic data
TR01 Transfer of patent right

Effective date of registration: 20191121

Address after: 215500 No.18, Zengfu Road, Baimao, Guli Town, Changshu, Suzhou, Jiangsu Province

Patentee after: Suzhou Zhigao Jiahua Technology Co.,Ltd.

Address before: 224000, Yingbin Road, Jiangsu, 9, Yancheng Institute Of Technology, Yancheng City

Patentee before: YANCHENG INSTITUTE OF TECHNOLOGY

TR01 Transfer of patent right
TR01 Transfer of patent right

Effective date of registration: 20240110

Address after: Building 3, Building 3310, No. 88 Xianshi Road, Changshu High tech Industrial Development Zone, Suzhou City, Jiangsu Province, 215500

Patentee after: Changshu Zijin Intellectual Property Service Co.,Ltd.

Address before: 215500 No.18, Baimao Zengfu Road, Guli Town, Changshu City, Suzhou City, Jiangsu Province

Patentee before: Suzhou Zhigao Jiahua Technology Co.,Ltd.

TR01 Transfer of patent right